At the Bulgarian Pharmaceutical Days 2026, organized by the Bulgarian Pharmaceutical Association, Novalac Aminova received the Product of the Year Award in the category “Foods for Special Medical Purposes.” With more than 1,000 participants, the event is the largest professional forum for pharmacists in Bulgaria.
Novalac Aminova provides nutritional support for infants and young children with severe food allergies. It contains only free amino acids and is free from cow’s milk protein, lactose and gluten. Because of its hypoallergenic formula, Novalac Aminova is classified as food for special medical purposes and has been covered by healthcare insurance in Bulgaria since January 2026 for children aged 12 to 36 months.
Allergy to cow's milk proteins (CMPA) develops in the first months of life, where symptoms of CMPA usually show as general discomfort of the child, inconsolable cry, poor weight gain, symptoms in the digestive system (diarrhea, vomiting, constipation) and symptoms on the skin (rash, itching, redness). Elimination from diet of cow's milk proteins, is the only way to manage Cow's Milk Allergy (CMA). If the baby is not breastfed, and is reacting to extensively hydrolyzed formulas, Novalac Aminova is the solution of choice. Additionally with added PAX® complex it treats regurgitation and normalizes stool consistency. The efficacy of Novalac formulas is evidenced in published clinical trials and so presents a secure and clinically proven choice for babies with CMPA.